Despite the supply difficulties and cost increases during the pandemic process, the Turkish pharmaceutical industry, which rapidly produces the drugs both in the Covid-19 treatment protocol and needed for all other treatments, and continues uninterrupted access of the society and healthcare workers to the drug, started 2023 fast. Finally, the pharmaceutical industry, which has increased its production momentum due to increasing diseases due to seasonal conditions, continues to take important steps in terms of community access to drugs. In a statement, the Pharmaceutical Industry Employers’ Union emphasized that ‘pharmaceutical production continues uninterruptedly to meet the needs of our citizens’.
The Turkish pharmaceutical industry, which works day and night to ensure that patients have uninterrupted access to medicines in the challenging conditions of the PANDEMIC, continues to increase its production in a way to meet the additional demand created by the increasing seasonal diseases, despite all the problems in the global supply chain. War Malkoç, General Secretary of the Pharmaceutical Industry Employers’ Union, made a statement on the subject; “The disruptions in the global trade and supply chain, which started in 2020 due to the pandemic and are still not fully resolved, as well as the excessive increases in commodity prices and production costs, have put our industry under a very serious burden, just like every other sector. However, the Turkish pharmaceutical industry, which does not leave our citizens without medicine even during the pandemic period, continues its production at full capacity with this awareness in this difficult period. said.
Malkoç said: “No one should doubt the production capacity and power of the Turkish pharmaceutical industry. Our production facilities in international standards continue their activities uninterruptedly. Thanks to this world-class infrastructure, we meet 90% of our country’s pharmaceutical needs through domestic production, as stated by our President. The membership of the Turkish Medicines and Medical Devices Agency of the Ministry of Health, the International Pharmaceutical Inspection Union and the International Compliance Council, is the clearest indicator of our country’s global competence in drug development, production and inspection. Our state and industry have never left our society without medicine, and there is no question of it. Thanks to our public institutions’ belief in the competence and power of our industry, our investments, our human resources, our technology and our experience, the Turkish pharmaceutical industry will also mark 2023 with its success. The increase in the amount of drugs we currently offer to the market is at a scale that will meet the needs and expectations of our citizens.”
“Our citizens’ access to medicine is a duty for us”
Savaş Malkoç continued his words as follows; “It is of course not correct to say that there were no problems with the supply of medicines during this period. There are global supply chain problems that are also reflected in the press in countries such as Germany, France and England. Due to the additional demand created by seasonal diseases, which increased significantly this year after the Covid pandemic, there is a global shortage of medicines, especially in cold medicines and antibiotics. However, as the Turkish pharmaceutical industry with a history of more than 100 years, we are working and producing with great sacrifice to meet the pharmaceutical needs of our citizens with full capacity 24/7, despite all the raw material, packaging material and active substance supply problems we experience. With this devoted work of our industry and the measures taken by our Ministry of Health, the problem of access to medicine is rapidly decreasing day by day. In this way, it is possible to say that this problem is felt much less when compared to many countries in Europe.”
Malkoç also stated that the strategic importance of having a strong domestic pharmaceutical industry in our country is better understood in these days when there are problems in the supply of drugs on a global scale, as in the pandemic period. Malkoç concluded his words by saying, “We are going through a period when we understand how vital it is to support the domestic and national pharmaceutical industry, which we have created with great difficulties, with all the means of our state, in order to ensure the stable access of our citizens to medicine.”
Source: (BYZHA) – Beyaz News Agency
